Retatrutide, a versatile drug, showed significant weight loss, musculoskeletal issues, and sleep apnea in clinical trials. The drug caused marked reduction in weight and reduced A1C levels in people with excess weight and type 2 diabetes. The results were reported in FirstWord, showing the drug's potential in addressing diverse health concerns.
More Top Stories
Tristan Luneau extends his stay with the Anaheim Ducks
Tristan Luneau has signed a six year, $43.2 million contract extension with the Anaheim Ducks. The deal was re...
Asian Games 2026 cricket tournament semi-finals
India and Sri Lanka are set to face off in the semi finals of the Asian Games 2026 cricket tournament. The mat...
The FTSE 100 index sees gains amid market fluctuations.
The FTSE 100 index opened up by 0.26% on Monday. The DAX index showed a rise of 0.53% and a 0.29% decline. Sto...
Twitch's 2026 report shows gaming content statistics
Twitch's State of Gaming 2026 report shows that approximately 8.6 billion hours of gaming content was viewed....
Premium Bonds Market Trends
NS&I Premium Bonds customers got positive updates through emails about changes. Traders are charging a 'Warsh...
FA Trophy first round draw reveals 32 matches for October 2026
The FA Trophy first round draw took place on Monday. Thirty two matches are set for October 24, 2026. Workingt...
Local Briefing · Community Report · Latest Update · Daily Digest · Weekly Review · News Roundup · Community Report · News Roundup · News Roundup · Community Report · Weekly Review · Community Report · Latest Update · Community Report · News Roundup · Daily Digest · Local Briefing · Latest Update · Local Briefing · Weekly Review · News Roundup · Weekly Review · Local Briefing · News Roundup · Daily Digest · News Roundup · Community Report · Daily Digest · Weekly Review · Community Report · Weekly Review · News Roundup · Community Report · Latest Update · Latest Update · Latest Update · Daily Digest · News Roundup · Community Report · Local Briefing